Our Assay Development Hub at Global Access Diagnostics offers a complete range of assay development services to researchers, developers, and manufacturers of rapid point-of-care assays and devices.
Our team of more than 41 scientists has extensive experience in dealing with monoplex or multiplex tests, device housing, and product design, both for unique test systems and our innovative enzyme activity detection (ELTABA) platform. We can help with everything from identifying the right proteins and custom antibody production to designing the most effective device and scaling up low-volume lateral flow manufacturing. Our work is carefully stage-gated, from proof of concept to launch. We review progress together and ensure we make the right decisions to develop your assay or product.
CASE STUDIES & NEWS ARTICLES
Norbrook launches groundbreaking diagnostic test for Liver Fluke
GADx Awarded Grand Prize for Maternal Health Innovation
New Study Investigates Biomarkers for Kidney Health Assessment
Botswana, a major animal health player on the African Continent
Botrytis: How on-site diagnostics can support the wine industry
Liver fluke test: Developing a rapid test to support farmers in response to antihelminthic resistance
How in-field diagnostics can reduce waste on farms and promote sustainable agriculture
Cystatin C test: Developing a rapid test to allow users to track kidney function
GET IN TOUCH
For sales inquiries please contact sales@globalaccessdx.com
For technical support please contact technicalsupport@globalaccessdx.com
Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.
Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.